Sign inJoin waitlistJoin the waitlist

Matthew Hickey

Medical Director, Ward 86 · University of California (San Francisco) School of Medicine

Credentials: ·

History

Ward 86 · University of California (San Francisco) School of Medicine
Present
University of California (San Francisco) School of Medicine
Present
University of California (San Francisco) School of Medicine
Present

University of California-San Francisco
2022–2024
University of California, San Francisco
University of California, San Francisco School of Medicine
2011–2015
Texas A&M University
2006–2009

Research

First Demonstration Project of Long-Acting Injectable Antiretroviral Therapy for Persons With and Without Detectable Human Immunodeficiency Virus (HIV) Viremia in an Urban HIV…
Clinical Infectious Diseases · 2023 · 118 citations
Demonstration Project of Long-Acting Antiretroviral Therapy in a Diverse Population of People With HIV
Annals of Internal Medicine · 2023 · 107 citations
Viral suppression rates in a safety-net HIV clinic in San Francisco destabilized during COVID-19
AIDS · 2020 · 99 citations

Diane Havlir
29 papers
Monica Gandhi
25 papers
Elizabeth Imbert
19 papers
Katerina Christopoulos
18 papers
Elvin Geng
11 papers
Charles Salmen
10 papers · 10 as a resident
Craig Cohen
10 papers
Gabriel Chamie
10 papers
AC
Asa Clemenzi-Allen
7 papers
Ayesha Appa
6 papers · 3 as a fellow
JC
Jonathan Colasanti
6 papers
Moira McNulty
6 papers

Grants

Research on End-User Acceptability.and Long-Term Impacts of HIV Cure Strategies (REALISE)
National Institute of Allergy and Infectious Diseases · R01
PI · $777.8K · Washington University
2026–2031
Community-Based Implementation of Hypertension Screening and Telehealth Systems in Kenya (COMPASS)
National Heart, Lung, and Blood Institute · R01
Contact PI · $1.2M · University of California, San Francisco
2025–2030
From Evidence to Scale: Implementation Science and Simulation Modeling to Transform HIV-Hypertension Care Integration
National Heart, Lung, and Blood Institute · R01
Contact PI · $2.3M · University of California, San Francisco
2026–2029
Staged Low-Barrier and Mobile Care to Improve Retention and Viral Suppression in Hard-To-Reach Vulnerable People Living With HIV
National Institute of Allergy and Infectious Diseases · R01
PI · $3.1M · University of California, San Francisco
2022–2027

Clinical trials

Multidisciplinary Low-Barrier and Mobile HIV Care to Improve Retention and Viral Suppression: Stakeholder-Engaged Design and Evaluation
Principal investigator · Recruiting
University of California, San Francisco
2024–2027